United States · FDA National Drug Code directory
Cyclobenzaprine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-274_5ab7642c-3c58-9a32-e063-6394a90a1796
- Product NDC
- 85766-274
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine hydrochloride
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200706
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (85766-274-01) · 85766-274-01
- 10 TABLET, FILM COATED in 1 BOTTLE (85766-274-10) · 85766-274-10
- 14 TABLET, FILM COATED in 1 BOTTLE (85766-274-14) · 85766-274-14
- 15 TABLET, FILM COATED in 1 BOTTLE (85766-274-15) · 85766-274-15
- 20 TABLET, FILM COATED in 1 BOTTLE (85766-274-20) · 85766-274-20
- 30 TABLET, FILM COATED in 1 BOTTLE (85766-274-30) · 85766-274-30
- 60 TABLET, FILM COATED in 1 BOTTLE (85766-274-60) · 85766-274-60
- 90 TABLET, FILM COATED in 1 BOTTLE (85766-274-90) · 85766-274-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →